Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin-Reference-Cited by-同舟云学术

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

Published:2016-02 Issue:2 Volume:69 Page:197-200
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Kamat Ashish M.,Briggman Joseph,Urbauer Diana L.,Svatek Robert,Nogueras González Graciela M.,Anderson Roosevelt,Grossman H. Barton,Prat Ferran,Dinney Colin P.

Publisher

Elsevier BV

Subject

Urology

Reference9 articles.

1. Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer;Kamat;Eur Urol,2014

2. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?;Herr;J Urol,2001

3. Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review;Zuiverloon;Eur Urol,2012

4. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer;Biot;Sci Transl Med,2012

5. Expert consensus document: consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer;Kamat;Nat Rev Urol,2015

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical significance and anti-tumor role of PRKG1 in bladder cancer;Frontiers in Immunology;2024-07-30

2. Development and Validation of Prognostic Nomogram to Predict Overall Survival for Older Patients Who Age 75 Years or Older With Urothelial Carcinoma of Bladder;JU Open Plus;2024-05

3. Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette–Guérin Therapy in Non-Muscle-Invasive Bladder Cancer;Cancers;2024-04-26

4. Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer;Cells;2024-04-18

5. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15